PEDIATRICS • PEDIATRICS

RIOCET-M

Levocetirizine Hcl 2.5mg & Montelukast 4mg Suspension (with Outer Carton) (Strawberry Flavour)

Schedule H Prescription Drug
Printed MRP: ₹105.00 (Incl. of all taxes)
★ PCD Franchise Offer: Attractive Margins
Packaging Form
60ml
Standard Specification
IP / BP / USP Pharmacopoeial Standards
Brand Family
RIOCET-M Series
Franchise Territory
District Monopoly Available
Order / Pay Online

Product Technical Snapshot

Official pharmaceutical registration and manufacturing parameters

Brand Name RIOCET-M
Active Formulation (Salt) Levocetirizine Hcl 2.5mg & Montelukast 4mg Suspension (with Outer Carton) (Strawberry Flavour)
Dosage Form PEDIATRICS
Packaging Presentation 60ml
Therapeutic Category PEDIATRICS
Regulatory Classification Schedule H Prescription Drug
Pharmacopoeial Standard IP / BP / USP Pharmacopoeial Standards
Quality Certifications WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
Marketed & Distributed By Riomedica Healthcare Pvt. Ltd. (Ambala Cantt & Panchkula, Haryana)
B2B Franchise Availability Monopoly PCD Franchise rights available across all Indian districts

What is RIOCET-M?

Therapeutic monograph and clinical profile

RIOCET-M (Levocetirizine Hcl 2.5mg & Montelukast 4mg Suspension (with Outer Carton) (Strawberry Flavour)) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 60ml, it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Allergic Rhinitis (Hay Fever) / Allergic Asthma Control.

Key Formulation Highlights

Why healthcare professionals recommend RIOCET-M

WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
DCGI Approved Formulation with Proven Chemical Purity
High Bioavailability & Predictable Pharmacokinetics
Premium Moisture-Proof Protective Packaging
Exclusive Monopoly PCD Pharma Franchise Rights Available

Therapeutic Uses & Clinical Indications

Conditions and clinical disorders managed by this medicine

Recommended Clinical Indications:

Allergic Rhinitis (Hay Fever) / Allergic Asthma Control

Pharmacological Mechanism of Action

How RIOCET-M acts biochemically in the body

Delivers targeted active therapeutic release with rapid absorption and high safety profile.

Dosage & Administration Guidance

Proper usage directions under clinical supervision

As directed by the physician or healthcare professional. Take with water at prescribed intervals.

Precautions, Warnings & Contraindications

Safety guidelines and patient health considerations

Clinical Safety & Medical Advice:

Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.

Possible Side Effects

Tolerability profile and reporting

Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.

Storage & Handling Instructions

Maintaining formulation stability and shelf-life

Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.

Exclusive PCD Pharma Franchise Opportunity for RIOCET-M

Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for RIOCET-M across India with comprehensive visual aids, prompt dispatch, and high profit margins.

Frequently Asked Questions (FAQs)

Common queries regarding RIOCET-M

What is RIOCET-M used for?
RIOCET-M is prescribed for Allergic Rhinitis (Hay Fever) / Allergic Asthma Control. Always follow physician dosage instructions.
What is the printed packaging and MRP of RIOCET-M?
The printed packaging is 60ml with an MRP of ₹105.00.
How can I get monopoly PCD franchise for RIOCET-M?
You can request district monopoly rights directly via sales@riomedicahealthcare.com or WhatsApp +91 82229 99973.
×

PCD Franchise Enquiry

Get monopoly rights, wholesale price list & free promotional visual aids.